Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4

Galactose Modified Liposomes for Effective Co-Delivery of Doxorubicin and Combretastatin A4

Bo Lian,1,* Hua Wei,2,* Ruiyan Pan,3,* Jingui Sun,4 Bo Zhang,3 Jingliang Wu,1 Xiujie Li,1 Guixiang Tian1 1School of Bioscience and Technology, Weifang Medical University, Weifang 261053, People’s Republic of China; 2Department of Endocrinology, ShouGuang Peoples’ Hospital, Weifan...

Full description

Bibliographic Details
Main Authors: Lian B, Wei H, Pan R, Sun J, Zhang B, Wu J, Li X, Tian G
Format: Article
Language:English
Published: Dove Medical Press 2021-01-01
Series:International Journal of Nanomedicine
Subjects:
liposomes
anti-hepatoma
co-delivery
combination therapy
Online Access:https://www.dovepress.com/galactose-modified-liposomes-for-effective-co-delivery-of-doxorubicin--peer-reviewed-article-IJN

Internet

https://www.dovepress.com/galactose-modified-liposomes-for-effective-co-delivery-of-doxorubicin--peer-reviewed-article-IJN

Similar Items